This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2009;12(3):131-3.

doi: 10.1159/000189624. Epub 2009 Feb 10.

Pharmacogenomics and public health

D Veenstra¹, W Burke

Affiliations

PMID: 19204414
PMCID: PMC2836943
DOI: 10.1159/000189624

Pharmacogenomics and public health

D Veenstra et al. Public Health Genomics. 2009.

. 2009;12(3):131-3.

doi: 10.1159/000189624. Epub 2009 Feb 10.

Authors

D Veenstra¹, W Burke

Affiliation

¹ Department of Pharmacy, Center for Genomics and Healthcare Equality, University of Washington, Seattle, Wash, USA.

PMID: 19204414
PMCID: PMC2836943
DOI: 10.1159/000189624

No abstract available

PubMed Disclaimer

Similar articles

Pharmacogenomics and public health: implementing 'populationalized' medicine.
Mette L, Mitropoulos K, Vozikis A, Patrinos GP. Mette L, et al. Pharmacogenomics. 2012 May;13(7):803-13. doi: 10.2217/pgs.12.52. Pharmacogenomics. 2012. PMID: 22594512 Review.
Public health pharmacogenomics.
Patrinos GP. Patrinos GP. Public Health Genomics. 2014;17(5-6):245-7. doi: 10.1159/000366459. Epub 2014 Oct 17. Public Health Genomics. 2014. PMID: 25341918 No abstract available.
Population pharmacogenomics: impact on public health and drug development.
Patrinos GP. Patrinos GP. Pharmacogenomics. 2018 Jan;19(1):3-6. doi: 10.2217/pgs-2017-0166. Epub 2017 Dec 1. Pharmacogenomics. 2018. PMID: 29191072 No abstract available.
Role of pharmacogenetics in public health and clinical health care: a SWOT analysis.
Kapoor R, Tan-Koi WC, Teo YY. Kapoor R, et al. Eur J Hum Genet. 2016 Dec;24(12):1651-1657. doi: 10.1038/ejhg.2016.114. Epub 2016 Aug 31. Eur J Hum Genet. 2016. PMID: 27577547 Free PMC article. Review.
Pharmacogenetics and pharmacogenomics: recent developments, their clinical relevance and some ethical, social, and legal implications.
Norbert PW, Roses AD. Norbert PW, et al. J Mol Med (Berl). 2003 Mar;81(3):135-40. doi: 10.1007/s00109-002-0415-6. J Mol Med (Berl). 2003. PMID: 12755119

See all similar articles

Cited by

Is individualized medicine more cost-effective? A systematic review.
Hatz MH, Schremser K, Rogowski WH. Hatz MH, et al. Pharmacoeconomics. 2014 May;32(5):443-55. doi: 10.1007/s40273-014-0143-0. Pharmacoeconomics. 2014. PMID: 24574059
End of the Beginning and Public Health Pharmacogenomics: Knowledge in 'Mode 2' and P5 Medicine.
Ozdemir V, Fisher E, Dove ES, Burton H, Wright GE, Masellis M, Warnich L. Ozdemir V, et al. Curr Pharmacogenomics Person Med. 2012 Jan 1;10(1):1-6. doi: 10.2174/1875692111201010001. Curr Pharmacogenomics Person Med. 2012. PMID: 22545073 Free PMC article. No abstract available.
Generic Cost-Effectiveness Models: A Proof of Concept of a Tool for Informed Decision-Making for Public Health Precision Medicine.
Snyder SR, Hao J, Cavallari LH, Geng Z, Elsey A, Johnson JA, Mohamed Z, Chaiyakunapruk N, Chong HY, Dahlui M, Shabaruddin FH, Patrinos GP, Mitropoulou C, Williams MS. Snyder SR, et al. Public Health Genomics. 2018;21(5-6):217-227. doi: 10.1159/000500725. Epub 2019 Jun 12. Public Health Genomics. 2018. PMID: 31189173 Free PMC article.

References

1. Carlson RJ. The disruptive nature of personalized medicine technologies: implications for the health care system. Public Health Genomics. 2009;12:180–184. - PubMed
1. Garrison LP. Will pharmacogenomics disrupt the US health care system? No. Public Health Genomics. 2009;12:185–190. - PubMed
1. Haga SB, Warner LR, O'Daniel J. The potential of a placebo/nocebo effect in pharmacogenetics. Public Health Genomics. 2009;12:158–162. - PMC - PubMed
1. Lee SSJ. Pharmacogenomics and the challenge of health disparities. Public Health Genomics. 2009;12:170–179. - PubMed
1. Paik S, Tang G, Shak S, Kim C, Baker J, Kim W, Cronin M, Baehner FL, Watson D, Bryant J, Costantino JP, Geyer CE, Jr, Wickerham DL, Wolmark N. Gene expression and benefit of chemotherapy in women with nodenegative, estrogen receptor-positive breast cancer. J Clin Oncol. 2006;24:3726–3734. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources